nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—Dermatitis bullous—Mechlorethamine—lymphatic system cancer	0.015	0.015	CcSEcCtD
Testosterone Propionate—Cognitive impairment—Methotrexate—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Testosterone Propionate—Azoospermia—Methotrexate—lymphatic system cancer	0.0141	0.0141	CcSEcCtD
Testosterone Propionate—Neoplasm—Teniposide—lymphatic system cancer	0.0132	0.0132	CcSEcCtD
Testosterone Propionate—Aggression—Bleomycin—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Testosterone Propionate—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00998	0.00998	CcSEcCtD
Testosterone Propionate—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00993	0.00993	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Teniposide—lymphatic system cancer	0.00977	0.00977	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Fludarabine—lymphatic system cancer	0.0093	0.0093	CcSEcCtD
Testosterone Propionate—Gamma-glutamyltransferase increased—Mitoxantrone—lymphatic system cancer	0.00926	0.00926	CcSEcCtD
Testosterone Propionate—Cognitive disorder—Methotrexate—lymphatic system cancer	0.00878	0.00878	CcSEcCtD
Testosterone Propionate—Alopecia—Mechlorethamine—lymphatic system cancer	0.00877	0.00877	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.00858	0.00858	CcSEcCtD
Testosterone Propionate—Dysuria—Fludarabine—lymphatic system cancer	0.00751	0.00751	CcSEcCtD
Testosterone Propionate—Neoplasm—Carmustine—lymphatic system cancer	0.00741	0.00741	CcSEcCtD
Testosterone Propionate—Haemoglobin—Teniposide—lymphatic system cancer	0.00735	0.00735	CcSEcCtD
Testosterone Propionate—Gynaecomastia—Carmustine—lymphatic system cancer	0.00733	0.00733	CcSEcCtD
Testosterone Propionate—Haemorrhage—Teniposide—lymphatic system cancer	0.00732	0.00732	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00705	0.00705	CcSEcCtD
Testosterone Propionate—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00685	0.00685	CcSEcCtD
Testosterone Propionate—Haematuria—Fludarabine—lymphatic system cancer	0.00683	0.00683	CcSEcCtD
Testosterone Propionate—Alopecia—Teniposide—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Testosterone Propionate—Haemoglobin—Fludarabine—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Testosterone Propionate—Haemorrhage—Fludarabine—lymphatic system cancer	0.00643	0.00643	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.00595	0.00595	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Testosterone Propionate—Alopecia—Fludarabine—lymphatic system cancer	0.00568	0.00568	CcSEcCtD
Testosterone Propionate—Malnutrition—Fludarabine—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Testosterone Propionate—Hypertension—Teniposide—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Testosterone Propionate—Confusional state—Teniposide—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Testosterone Propionate—Oedema—Teniposide—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00519	0.00519	CcSEcCtD
Testosterone Propionate—Malaise—Fludarabine—lymphatic system cancer	0.00505	0.00505	CcSEcCtD
Testosterone Propionate—Haematuria—Bleomycin—lymphatic system cancer	0.00501	0.00501	CcSEcCtD
Testosterone Propionate—Pruritus—Mechlorethamine—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Testosterone Propionate—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00482	0.00482	CcSEcCtD
Testosterone Propionate—Myalgia—Fludarabine—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Testosterone Propionate—Arthralgia—Fludarabine—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Testosterone Propionate—Haemoglobin—Bleomycin—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Testosterone Propionate—Haemorrhage—Bleomycin—lymphatic system cancer	0.00472	0.00472	CcSEcCtD
Testosterone Propionate—Discomfort—Fludarabine—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Testosterone Propionate—Dyspnoea—Teniposide—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Testosterone Propionate—Confusional state—Fludarabine—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Testosterone Propionate—Dysuria—Vincristine—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Testosterone Propionate—Oedema—Fludarabine—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Testosterone Propionate—Vomiting—Mechlorethamine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Testosterone Propionate—Rash—Mechlorethamine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Testosterone Propionate—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Testosterone Propionate—Weight increased—Mitoxantrone—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Teniposide—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Testosterone Propionate—Nausea—Mechlorethamine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Testosterone Propionate—Alopecia—Bleomycin—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Testosterone Propionate—Haemoglobin—Carmustine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Testosterone Propionate—Urticaria—Teniposide—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Testosterone Propionate—Haemorrhage—Carmustine—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Testosterone Propionate—Abdominal pain—Teniposide—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Testosterone Propionate—Paraesthesia—Fludarabine—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Testosterone Propionate—Dyspnoea—Fludarabine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Testosterone Propionate—Haematuria—Mitoxantrone—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Testosterone Propionate—Fatigue—Fludarabine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Testosterone Propionate—Inflammation—Methotrexate—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Testosterone Propionate—Pain—Fludarabine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Testosterone Propionate—Urethral disorder—Vincristine—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Testosterone Propionate—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Teniposide—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Testosterone Propionate—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Testosterone Propionate—Asthenia—Teniposide—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Testosterone Propionate—Malaise—Bleomycin—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Testosterone Propionate—Pruritus—Teniposide—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Testosterone Propionate—Alopecia—Carmustine—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Testosterone Propionate—Mental disorder—Carmustine—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Testosterone Propionate—Malnutrition—Carmustine—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Testosterone Propionate—Angiopathy—Vincristine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Testosterone Propionate—Diarrhoea—Teniposide—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Testosterone Propionate—Myalgia—Bleomycin—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Testosterone Propionate—Alopecia—Vincristine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Testosterone Propionate—Discomfort—Bleomycin—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Testosterone Propionate—Mental disorder—Vincristine—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Testosterone Propionate—Neoplasm—Methotrexate—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Testosterone Propionate—Gynaecomastia—Methotrexate—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Testosterone Propionate—Alopecia—Mitoxantrone—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Testosterone Propionate—Confusional state—Bleomycin—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Testosterone Propionate—Oedema—Bleomycin—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Testosterone Propionate—Vomiting—Teniposide—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Testosterone Propionate—Asthenia—Fludarabine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Testosterone Propionate—Rash—Teniposide—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Testosterone Propionate—Dermatitis—Teniposide—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Testosterone Propionate—Headache—Teniposide—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Testosterone Propionate—Pruritus—Fludarabine—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Testosterone Propionate—Diarrhoea—Fludarabine—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Testosterone Propionate—Hypertension—Carmustine—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Testosterone Propionate—Nausea—Teniposide—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Testosterone Propionate—Myalgia—Carmustine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Testosterone Propionate—Anxiety—Carmustine—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Testosterone Propionate—Paraesthesia—Bleomycin—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Testosterone Propionate—Malaise—Mitoxantrone—lymphatic system cancer	0.003	0.003	CcSEcCtD
Testosterone Propionate—Dyspnoea—Bleomycin—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Testosterone Propionate—Hypertension—Vincristine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Testosterone Propionate—Confusional state—Carmustine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Testosterone Propionate—Oedema—Carmustine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Testosterone Propionate—Myalgia—Vincristine—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Testosterone Propionate—Vomiting—Fludarabine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Testosterone Propionate—Rash—Fludarabine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Testosterone Propionate—Dermatitis—Fludarabine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Testosterone Propionate—Hypertension—Mitoxantrone—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Testosterone Propionate—Pain—Bleomycin—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Testosterone Propionate—Headache—Fludarabine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Testosterone Propionate—Myalgia—Mitoxantrone—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Testosterone Propionate—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Testosterone Propionate—Anxiety—Mitoxantrone—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Testosterone Propionate—Discomfort—Mitoxantrone—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Testosterone Propionate—Oedema—Vincristine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Testosterone Propionate—Confusional state—Mitoxantrone—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Vincristine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Testosterone Propionate—Oedema—Mitoxantrone—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Testosterone Propionate—Nausea—Fludarabine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Testosterone Propionate—Urticaria—Bleomycin—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Testosterone Propionate—Insomnia—Carmustine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Testosterone Propionate—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Testosterone Propionate—Irritability—Methotrexate—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Testosterone Propionate—Paraesthesia—Carmustine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Testosterone Propionate—Dyspnoea—Carmustine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Testosterone Propionate—Insomnia—Vincristine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Testosterone Propionate—Paraesthesia—Vincristine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Testosterone Propionate—Pain—Carmustine—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Testosterone Propionate—Breast disorder—Methotrexate—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Testosterone Propionate—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Testosterone Propionate—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Carmustine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Testosterone Propionate—Fatigue—Vincristine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Testosterone Propionate—Asthenia—Bleomycin—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Testosterone Propionate—Pain—Vincristine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Testosterone Propionate—Pruritus—Bleomycin—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Testosterone Propionate—Fatigue—Mitoxantrone—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Testosterone Propionate—Pain—Mitoxantrone—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Testosterone Propionate—Abdominal pain—Carmustine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Testosterone Propionate—Dysuria—Methotrexate—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Testosterone Propionate—Abdominal pain—Vincristine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Testosterone Propionate—Urticaria—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Carmustine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Testosterone Propionate—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Testosterone Propionate—Vomiting—Bleomycin—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Testosterone Propionate—Rash—Bleomycin—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Testosterone Propionate—Dermatitis—Bleomycin—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Testosterone Propionate—Asthenia—Carmustine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Vincristine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Testosterone Propionate—Haematuria—Methotrexate—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.002	0.002	CcSEcCtD
Testosterone Propionate—Asthenia—Vincristine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Testosterone Propionate—Diarrhoea—Carmustine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Testosterone Propionate—Nausea—Bleomycin—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Testosterone Propionate—Asthenia—Mitoxantrone—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Testosterone Propionate—Dizziness—Carmustine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Testosterone Propionate—Haemoglobin—Methotrexate—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Testosterone Propionate—Diarrhoea—Vincristine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Testosterone Propionate—Haemorrhage—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Testosterone Propionate—Urethral disorder—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Testosterone Propionate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Testosterone Propionate—Vomiting—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Testosterone Propionate—Dizziness—Vincristine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Testosterone Propionate—Rash—Carmustine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Testosterone Propionate—Dermatitis—Carmustine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Testosterone Propionate—Headache—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Testosterone Propionate—Vomiting—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Testosterone Propionate—Rash—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Testosterone Propionate—Dermatitis—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Testosterone Propionate—Headache—Vincristine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Testosterone Propionate—Nausea—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Testosterone Propionate—Angiopathy—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Testosterone Propionate—Vomiting—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Testosterone Propionate—Immune system disorder—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Testosterone Propionate—Rash—Mitoxantrone—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Testosterone Propionate—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Testosterone Propionate—Headache—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Testosterone Propionate—Alopecia—Methotrexate—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Testosterone Propionate—Mental disorder—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Testosterone Propionate—Malnutrition—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Testosterone Propionate—Nausea—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Testosterone Propionate—Nausea—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Testosterone Propionate—Malaise—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Testosterone Propionate—Arthralgia—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Testosterone Propionate—Myalgia—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Testosterone Propionate—Discomfort—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Testosterone Propionate—Confusional state—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Testosterone Propionate—Skin disorder—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Testosterone Propionate—Insomnia—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Testosterone Propionate—Paraesthesia—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Testosterone Propionate—Dyspnoea—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Testosterone Propionate—Fatigue—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Testosterone Propionate—Pain—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Testosterone Propionate—Urticaria—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Testosterone Propionate—Abdominal pain—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000998	0.000998	CcSEcCtD
Testosterone Propionate—Asthenia—Methotrexate—lymphatic system cancer	0.000972	0.000972	CcSEcCtD
Testosterone Propionate—Pruritus—Methotrexate—lymphatic system cancer	0.000958	0.000958	CcSEcCtD
Testosterone Propionate—Diarrhoea—Methotrexate—lymphatic system cancer	0.000927	0.000927	CcSEcCtD
Testosterone Propionate—Dizziness—Methotrexate—lymphatic system cancer	0.000896	0.000896	CcSEcCtD
Testosterone Propionate—Vomiting—Methotrexate—lymphatic system cancer	0.000861	0.000861	CcSEcCtD
Testosterone Propionate—Rash—Methotrexate—lymphatic system cancer	0.000854	0.000854	CcSEcCtD
Testosterone Propionate—Dermatitis—Methotrexate—lymphatic system cancer	0.000853	0.000853	CcSEcCtD
Testosterone Propionate—Headache—Methotrexate—lymphatic system cancer	0.000848	0.000848	CcSEcCtD
Testosterone Propionate—Nausea—Methotrexate—lymphatic system cancer	0.000805	0.000805	CcSEcCtD
